| NCT Number | NCT07713290 |
| Lead Sponsor | Beijing Gene Key Life Technology Co., Ltd |
| Conditions | Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer |
| Enrollment | 6 participants |
| Start Date | 2025-04-03 |
| Primary Completion | 2026-11-12 (estimated) |
| Study Completion | 2027-02-28 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-20 |